Vectibix

The below information on Vectibix has been taken from official FDA sources, but we cannot guarantee it's accuracy. Please use this site for educational purposes only. This site does not replace a proper discussion with your doctor.


    Brand Name:Vectibix
    Generic:Panitumumab
    Availability:Prescription
This drug was approved by the FDA in one form or another on:
2006-09-27 ,
This drug is made in one form or another by the following companies:
Amgen, Inc.
This drug is available in the following forms:
Intravenous Injections
View the actual FDA approved label for this drug at the following links:
http://www.fda.gov/cder/foi/label/2006/125147s0000lbl.pdf

About Vectibix

Vectibix is a chemotherapy medicine (medicine used to kill cancer cells). It is given in a vein (I.V. infusion). Vectibix is used to treat a type of cancer of the colon or rectum (EGRF-expressing colorectal carcinoma) that has spread to other areas of the body (metastatic) on or after treatment with standard chemotherapy.

At this time, it is not known whether Vectibix will improve symptoms of EGFR-expressing, metastatic colorectal cancer or help these patients live longer.

Vectibix has not been studied in children.

Side Effects of Vectibix

  • Severe skin reactions. Vectibix may cause pimples, itching, red colored skin, rash, peeling skin, dry skin and cracks in the skin. Infection can develop and may lead to death. These severe reactions may also happen to the stomach and intestine lining, eyes and nails. Call your healthcare professional right away if you have any skin or eye reaction.
  • Sun sensitivity. Sunlight can worsen skin reactions so wear sunscreen and hats and limit sun exposure while receiving Vectibix.
  • Severe infusion reactions may occur during I.V. infusion with Vectibix. Sudden symptoms include trouble breathing, shortness of breath, fever, chills and low blood pressure.
  • A severe lung problem called pulmonary fibrosis that may lead to death.
  • Diarrhea.Diarrhea may be more severe, and may lead to death, when used with other chemotherapy medicines including irinotecan, bolus 5-fluorouracil, and leukovorin (IFL). The use of Vectibix with IFL is not recommended.
  • Loss of blood salts (electrolytes)including magnesium and calcium. Your healthcare professional should monitor your blood and treat low electrolyte levels.
  • Other side effectsthat may occur with Vectibix include: tiredness, stomach area pain, nausea, constipation, vomiting, cough and swelling of arms and legs.

Interactions with Vectibix

It is not known if Vectibix and other medicines can interact with each other. Tell your healthcare professional about all the medicines you take including prescription and non-prescription medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of them with you to show your healthcare professional.

Search the Web for more info:  


Recent Forum Posts on Vectibix

Vectibix Users

Hi, I started Vectibix August 12 2008. Treatment for SCC where tumour is internal, near the spine. The good news is reduction in tumour size. This is confirmed after a CAT scan 8 weeks into the treatment. The difficulty is dealing with the skid damage. Just heard today this treatment is not for just 10 weeks. I should expect to use Vectibix for at least 12 to 18 months to determine effectiveness. If you have any information on its use please add to the forum. Jennie


Post a New Comment/Question on Vectibix in our forums.